Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$9.08

Avg closing price
Price range

16 Jim Simons Bellerophon Therapeutics Trades

The first Bellerophon Therapeutics trade was made in Q1 2020. Since then Jim Simons bought shares five more times and sold shares on ten occasions. The investor completely sold their stake between Q3 2022 and Q4 2023.

Avg closing price
Price range
Sold -59.5k shares Q4 2023
Avg closing price $0.35
Price range $0.10 - $0.39
Sold 23.0% shares (-17.8k shares) Q3 2023
Avg closing price $0.49
Price range $0.38 - $0.76
Sold 54.5% shares (-92.6k shares) Q2 2023
Avg closing price $6.44
Price range $0.68 - $12.39
Sold 1.1% shares (-1.9k shares) Q1 2023
Avg closing price $3.48
Price range $0.90 - $7.89
Sold 12.4% shares (-24.4k shares) Q4 2022
Avg closing price $1.02
Price range $0.67 - $1.20
Sold 6.3% shares (-13.2k shares) Q3 2022
Avg closing price $1.31
Price range $0.96 - $1.69
Increased shares by 13.0% (+24.1k shares) Q2 2022
Avg closing price $1.34
Price range $0.85 - $2.36
Increased shares by 3.6% (+6.4k shares) Q1 2022
Avg closing price $2.38
Price range $1.82 - $3.24
Sold 11.3% shares (-22.8k shares) Q4 2021
Avg closing price $3.32
Price range $2.36 - $4.05
Sold 21.5% shares (-55.4k shares) Q3 2021
Avg closing price $4.17
Price range $3.75 - $4.86
Increased shares by 10.0% (+23.3k shares) Q2 2021
Avg closing price $4.49
Price range $3.83 - $5.65
Increased shares by 9.1% (+19.5k shares) Q1 2021
Avg closing price $6.96
Price range $5.07 - $8.27
Sold 13.7% shares (-34k shares) Q4 2020
Avg closing price $8.19
Price range $6.12 - $10.37
Sold 16.7% shares (-49.8k shares) Q3 2020
Avg closing price $11.76
Price range $9.27 - $13.79
Increased shares by 99.8% (+149k shares) Q2 2020
Avg closing price $13.99
Price range $9.43 - $20.28
New holding (+149k shares) Q1 2020
Avg closing price $6.70
Price range $3.39 - $18.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!